249 related articles for article (PubMed ID: 24838473)
1. Genetic and epigenetic characteristics of FSHD-associated 4q and 10q D4Z4 that are distinct from non-4q/10q D4Z4 homologs.
Zeng W; Chen YY; Newkirk DA; Wu B; Balog J; Kong X; Ball AR; Zanotti S; Tawil R; Hashimoto N; Mortazavi A; van der Maarel SM; Yokomori K
Hum Mutat; 2014 Aug; 35(8):998-1010. PubMed ID: 24838473
[TBL] [Abstract][Full Text] [Related]
2. Autosomal dominant in cis D4Z4 repeat array duplication alleles in facioscapulohumeral dystrophy.
Lemmers RJLF; Butterfield R; van der Vliet PJ; de Bleecker JL; van der Pol L; Dunn DM; Erasmus CE; D'Hooghe M; Verhoeven K; Balog J; Bigot A; van Engelen B; Statland J; Bugiardini E; van der Stoep N; Evangelista T; Marini-Bettolo C; van den Bergh P; Tawil R; Voermans NC; Vissing J; Weiss RB; van der Maarel SM
Brain; 2024 Feb; 147(2):414-426. PubMed ID: 37703328
[TBL] [Abstract][Full Text] [Related]
3. Exchange of subtelomeric regions between chromosomes 4q and 10q reverts the FSHD genotype and phenotype.
Ma Y; Schwager Karpukhina A; Dib C; Gautier C; Hermine O; Allemand E; Vassetzky YS
Sci Adv; 2024 May; 10(18):eadl1922. PubMed ID: 38691604
[TBL] [Abstract][Full Text] [Related]
4. Facioscapulohumeral Muscular Dystrophy.
Statland JM; Tawil R
Continuum (Minneap Minn); 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):1916-1931. PubMed ID: 27922500
[TBL] [Abstract][Full Text] [Related]
5. A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4.
Sasaki-Honda M; Jonouchi T; Arai M; Hotta A; Mitsuhashi S; Nishino I; Matsuda R; Sakurai H
Hum Mol Genet; 2018 Dec; 27(23):4024-4035. PubMed ID: 30107443
[TBL] [Abstract][Full Text] [Related]
6. Engineered FSHD mutations results in D4Z4 heterochromatin disruption and feedforward DUX4 network activation.
Kong X; Nguyen NV; Li Y; Sakr JS; Williams K; Sharifi S; Chau J; Bayrakci A; Mizuno S; Takahashi S; Kiyono T; Tawil R; Mortazavi A; Yokomori K
iScience; 2024 Apr; 27(4):109357. PubMed ID: 38510139
[TBL] [Abstract][Full Text] [Related]
7. Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy.
Lemmers RJ; Wohlgemuth M; van der Gaag KJ; van der Vliet PJ; van Teijlingen CM; de Knijff P; Padberg GW; Frants RR; van der Maarel SM
Am J Hum Genet; 2007 Nov; 81(5):884-94. PubMed ID: 17924332
[TBL] [Abstract][Full Text] [Related]
8. Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.
van der Maarel SM; Tawil R; Tapscott SJ
Trends Mol Med; 2011 May; 17(5):252-8. PubMed ID: 21288772
[TBL] [Abstract][Full Text] [Related]
9. Facioscapulohumeral muscular dystrophy: consequences of chromatin relaxation.
van der Maarel SM; Miller DG; Tawil R; Filippova GN; Tapscott SJ
Curr Opin Neurol; 2012 Oct; 25(5):614-20. PubMed ID: 22892954
[TBL] [Abstract][Full Text] [Related]
10. Does DNA Methylation Matter in FSHD?
Salsi V; Magdinier F; Tupler R
Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32121044
[TBL] [Abstract][Full Text] [Related]
11. Large family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy.
Jones TI; Himeda CL; Perez DP; Jones PL
Neuromuscul Disord; 2017 Mar; 27(3):221-238. PubMed ID: 28161093
[TBL] [Abstract][Full Text] [Related]
12. DUX4 promotes transcription of FRG2 by directly activating its promoter in facioscapulohumeral muscular dystrophy.
Thijssen PE; Balog J; Yao Z; Pham TP; Tawil R; Tapscott SJ; Van der Maarel SM
Skelet Muscle; 2014; 4():19. PubMed ID: 25789155
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of facioscapulohumeral muscular dystrophy 2.
de Greef JC; Lemmers RJ; Camaño P; Day JW; Sacconi S; Dunand M; van Engelen BG; Kiuru-Enari S; Padberg GW; Rosa AL; Desnuelle C; Spuler S; Tarnopolsky M; Venance SL; Frants RR; van der Maarel SM; Tawil R
Neurology; 2010 Oct; 75(17):1548-54. PubMed ID: 20975055
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei.
Vanderplanck C; Tassin A; Ansseau E; Charron S; Wauters A; Lancelot C; Vancutsem K; Laoudj-Chenivesse D; Belayew A; Coppée F
Skelet Muscle; 2018 Jan; 8(1):2. PubMed ID: 29329560
[TBL] [Abstract][Full Text] [Related]
15. Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene.
Himeda CL; Debarnot C; Homma S; Beermann ML; Miller JB; Jones PL; Jones TI
Mol Cell Biol; 2014 Jun; 34(11):1942-55. PubMed ID: 24636994
[TBL] [Abstract][Full Text] [Related]
16. Dominant lethal pathologies in male mice engineered to contain an X-linked DUX4 transgene.
Dandapat A; Bosnakovski D; Hartweck LM; Arpke RW; Baltgalvis KA; Vang D; Baik J; Darabi R; Perlingeiro RC; Hamra FK; Gupta K; Lowe DA; Kyba M
Cell Rep; 2014 Sep; 8(5):1484-96. PubMed ID: 25176645
[TBL] [Abstract][Full Text] [Related]
17. The FSHD atrophic myotube phenotype is caused by DUX4 expression.
Vanderplanck C; Ansseau E; Charron S; Stricwant N; Tassin A; Laoudj-Chenivesse D; Wilton SD; Coppée F; Belayew A
PLoS One; 2011; 6(10):e26820. PubMed ID: 22053214
[TBL] [Abstract][Full Text] [Related]
18. Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy.
Ricci G; Scionti I; Sera F; Govi M; D'Amico R; Frambolli I; Mele F; Filosto M; Vercelli L; Ruggiero L; Berardinelli A; Angelini C; Antonini G; Bucci E; Cao M; Daolio J; Di Muzio A; Di Leo R; Galluzzi G; Iannaccone E; Maggi L; Maruotti V; Moggio M; Mongini T; Morandi L; Nikolic A; Pastorello E; Ricci E; Rodolico C; Santoro L; Servida M; Siciliano G; Tomelleri G; Tupler R
Brain; 2013 Nov; 136(Pt 11):3408-17. PubMed ID: 24030947
[TBL] [Abstract][Full Text] [Related]
19. Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy.
Clapp J; Mitchell LM; Bolland DJ; Fantes J; Corcoran AE; Scotting PJ; Armour JA; Hewitt JE
Am J Hum Genet; 2007 Aug; 81(2):264-79. PubMed ID: 17668377
[TBL] [Abstract][Full Text] [Related]
20. Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy.
Lemmers RJ; Wohlgemuth M; Frants RR; Padberg GW; Morava E; van der Maarel SM
Am J Hum Genet; 2004 Dec; 75(6):1124-30. PubMed ID: 15467981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
